Clinical Trial Update: Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing Avelumab plus a second-generation androgen deprivation therapy in African American men with metastatic castration-resistant prost…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Jodi Layton, MD | Conditions: Metastatic Castration-resistant Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-01-18